Form D Explorer

Inspect source fieldsReport a record issue

Form D — PLEOPHARMA, INC.

0001801323-26-000001 · filed Aug 10, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$15,000,000
Reported amount sold
$5,500,000
Minimum investment
$50,000
Investors
11
Sales commission
$50,000
Finders' fees
$0

Issuer

Name
PLEOPHARMA, INC.
CIK
1801323
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
518 KIMBERTON RD.
PHOENIXVILLE, Pennsylvania 19460
Phone
(610) 937-2882

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗